Gladstone NOW: The Campaign Join Us on the Journey ✕
346 - 360 of 1427 Results Clear All
San Francisco Business Times—Gladstone Institutes announced a plan to expand on its current building in the Mission Bay neighborhood of San Francisco, with construction beginning in 2024. The expansion will provide space for over 12 new labs.
Institutional News
Building expansion will provide space for over a dozen new labs
Institutional News News Release
Science is Fun Podcast—Assistant Investigator Seth Shipman describes his remarkable technological advance repurposing CRISPR gene editing technology to record information inside living cells.
Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
Featuring Black scientists throughout history
Elevated Voices Diversity
A Q&A with Gladstone Investigator Benoit Bruneau
Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab
Past PUMAS interns share how the program has impacted their scientific journeys
Student Outreach and Science Education
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
As his interest in lab management began to grow, Aditya Naik jumped on the opportunity to join the newly formed Pelka lab at Gladstone
Research Associates Committee Profile Pelka Lab
Many changes to the genomes of early humans had opposing effects from each other, possibly because of a delicate balance between improved cognition and psychiatric disease risk
News Release Research (Publication) Data Science and Biotechnology Pollard Lab
STAT News—The Parker Institute for Cancer Immunotherapy has expanded to include a new center at Gladstone Institutes. Center Director Alex Marson says the funding will enable Gladstone scientists to take on bold, high-risk ideas and create better cell therapies for cancer.
Institutional News Cancer Genomic Immunology Marson Lab
Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience
Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab
See what we've been up to in 2022
Communications History
Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter
Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab
San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
Revisit some of Gladstone’s most important stories from the past year
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease Infectious Disease
